Stocktoria
MapLight Therapeutics, Inc. MPLT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2025-10-27
MapLight Therapeutics, Inc. statistics & valuation
Market cap$1.4B
P / B3.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 |
|---|---|---|
| Return on assets | -33.6% | -56.7% |
| Return on equity | -35.2% | 40.1% |
| Current ratio | 20.01 | 7.20 |
Source: SEC EDGAR filings · CIK 0001770069 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.